PKC-y is important in cell growth, apoptosis, and secretion. Recent studies show its stability is regulated by tyrosine phosphorylation (TYR-P), which can be stimulated by a number of agents. Many of these stimuli also activate phospholipase C (PLC) cascades and little is known about the relationship between these cascades and PKC-y TYR-P. Cholecystokinin (CCK) stimulates PKCs but it is unknown if it causes PKC-y TYR-P and if so, the relationship between these cascades is unknown. In rat pancreatic acini, CCK-8 stimulated rapid PKC-y TYR-P by activation of the low affinity CCK A receptor state. TPA had a similar effect. BAPTA did not decrease CCK-stimulated PKC-y TYR-P but instead, increased it. A23187 did not stimulate PKC-y TYR-P. Wortmannin and LY 294002 did not alter CCK-stimulated PKC-y TYR-P. GF 109203X, at low concentrations, increased PKC-y TYR-P stimulated by CCK or TPA and at higher concentrations, inhibited it. The cPKC inhibitors, Gö 6976 and safingol, caused a similar increase in TPA-and CCK-stimulated PKC-y TYR-P. These results demonstrate that CCK A receptor activation causes PKC-y TYR-P through activation of only one of its two receptor affinity states. This PKC-y TYR-P is not directly influenced by changes in [Ca 2 + ] i ; however, the resultant activation of PKC-a has an inhibitory effect. Therefore, CCK activates both stimulatory and inhibitory PKC cascades regulating PKC-y TYR-P and, hence, likely plays an important role in regulating PKC-y degradation and cellular abundance. Published by Elsevier Science B.V.
Introduction
The peptide, cholecystokinin (CCK), functions as both a neurotransmitter (in the central nervous system and gastrointestinal tract) as well as a hormone in the gastrointestinal tract with numerous biologic effects [1] . In the central nervous system CCK is one of the abundant neuropeptides and is involved in such diverse actions as modulating dopamine release, satiety, morphine-induced analgesia, and the induction of panic attacks [2] . In the gastrointestinal tract, CCK is a physiological regulator of postprandial pancreatic secretion, gallbladder contraction, gastric emptying, and colonic motility [1, 3] .
The actions of CCK-related peptides (CCK, gastrin) are mediated by two different subtypes of CCK receptors which are members of the G protein-coupled heptahelical superfamily [3, 4] : a CCK A receptor with high affinity for sulfated CCK peptides only, and a CCK B receptor with high affinity for both sulfated CCK and gastrin analogues [3] . The cellular basis of action of CCK at the CCK A -R, which is widely expressed in the gastrointestinal tract and central nervous system, has been extensively studied in pancreatic acinar cells where CCK stimulates enzyme secretion [1, 4, 5] , growth [6] , development [7] , protein synthesis [1, 5] , and regulation of c-fos, c-Jun and c-myc expression [8] . Extensive studies show that CCK causes activation of phospholipase A 2 , phospholipase D, and phospholipase C (PLC) [5] . The activation of PLC results in generation of diacylglycerol and increased inositol 1,4,5-trisphosphate with subsequent activation of protein kinase C (PKC), stimulation of increases in intracellular calcium concentration, and activation of mi-togen-activated protein kinase (MAPK) signaling pathways [5] . Recent studies have demonstrated that CCK A receptor activation [9] [10] [11] , similar to the activation in different tissues by integrins, bioactive lipids, various growth factors, and some G protein-coupled receptors, causes stimulation of tyrosine phosphorylation of a number of proteins [5, 12, 13] . With other stimulants, activation of this important intracellular pathway has been shown to be particularly important in mediating cellular growth, differentiation, motility, and adaptation to cellular stresses [12, 13] .
With CCK A receptor activation, similar to other stimulants which activate PLC and tyrosine kinases, the relationship between activation of both of these transduction cascades remains poorly defined, as well as their respective roles in many cell functions such as growth and differentiation. In this regard, the protein kinase C delta (PKC-y) isoform is of particular interest, because numerous studies demonstrate this serine -threonine kinase is not only activated by diacylglycerol from PLC and PLD activation, but also undergoes tyrosine phosphorylation itself [14, 15] , which can either increase [14,16 -18] or decrease [14, 19, 20] its kinase activity. Furthermore, tyrosine phosphorylation of PKC-y is an important means of regulating its cell abundance, because a recent study demonstrates that PKC-y tyrosine phosphorylation increases its instability, which results in increased degradation [21] . PKC-y activation has been proposed to be involved in a wide range of cellular responses including regulation of cell growth, differentiation, apoptosis, tumor suppression, secretion (fluid and electrolyte), various ion channels [L-channels, Na-H + exchangers (GLUT-4)], phosphoinositide hydrolysis, and prostaglandin formation [14,16,22 -24] .
Four different PKC isoforms have been detected in pancreatic acinar cells, including the conventional PKC (cPKC), PKC-a, the novel PKC (nPKC) isoforms, PKC-y and PKC-q, and the atypical isoform, PKC-~ [25, 26] . Whereas the role of stimulation of the PLC cascade by CCK A receptor activation resulting in stimulation of the classical PKC isoform due to increases in cytosolic calcium secondary to the generation of phosphoinositides and increases in diacylglycerol generation due to the breakdown of phospholipids, have been extensively studied [5] , little is known about the ability of CCK to activate nPKCs such as PKC-y. No studies have examined whether CCK can stimulate tyrosine phosphorylation of PKC-y or the possible relationships between this process and activation of the PLC cascade.
In the present study using dispersed rat pancreatic acini, we show that CCK A receptor activation results in a rapid tyrosine phosphorylation of PKC-y. This tyrosine phosphorylation is due to activation only of the low affinity state of the CCK A receptor, and is not dependent directly on changes in cytosolic calcium, and our results show for the first time that tyrosine phosphorylation of PKC-y is regulated in a positive and negative manner by activation of conventional and novel PKCs in the acinar cell.
Materials and methods

Materials
Male Wistar rats (150-200 g) were obtained from the Small Animals Section, Veterinary Resources Branch, NIH, Bethesda, MD or from the Animal Farm, Faculty of Veterinary, UEX, Spain. Purified collagenase (type CLSPA) from Worthington Biochemicals, Freehold, NJ; COOH-terminal octapeptide of cholecystokinin (CCK-8) was obtained from Peninsula Laboratories, Belmont, CA; CCK-JMV was obtained from Research Plus Inc., Bayonne, NJ. Anti-phosphotyrosine mAb (PY20), anti-p125 FAK mAb, anti-paxillin mAb, anti-PKC-a mAb, and anti-PKC-y mAb were from Transduction Laboratories, Lexington, KY. Anti-PKC-y polyclonal Ab and goat anti-rabbit IgG -horseradish peroxidase conjugate were from Santa Cruz Biotechnology, Inc., Santa Cruz, CA. Anti-phosphotyrosine mAb, myelin basic protein, and recombinant protein A -agarose were from Upstate Biotechnology Inc., Lake Placid, NY. GF 109203X, safingol, Gö 6976, calcium ionophore, A23187, and thapsigargin were from Calbiochem, La Jolla, CA. Soybean trypsin inhibitor (SBTI), dimethyl sulfoxide (DMSO), Triton X-100, 12-O-tetradecanoylphorbol 13-acetate (TPA), and deoxycholic acid were from Sigma, St. Louis, MO; phenylmethanesulfonyl fluoride (PMSF) was from Fluka, Ronkonkoma, NY. Phosphate-buffered saline (PBS), pH 7.4, was from Biofluids, Rockville, MD; basal medium Eagle (BME) amino acids and BME vitamin solution were from Gibco Laboratories, Grand Island, NY. Bovine serum albumin (BSA) fraction V was from Miles Inc., Kankakee, IL. Aprotinin, leupeptin, and 4-[2-hydroxyethyl]-1-piperazine ethanesulfonic acid (HEPES) were from Boehringer Mannheim Biochemicals, Indianapolis, IN. Rabbit anti-mouse IgGhorseradish peroxidase conjugate and enhanced chemiluminescence detection reagents were from Pierce, Rockford, IL. Sodium dodecyl sulfate (SDS), 2-mercaptoethanol, protein assay dye reagent, Tris/glycine/SDS buffer (10-times concentrated), and Tris/glycine buffer (10 times concentrated) were from Bio-Rad, Richmond, CA. BAPTA acetoxymethyl ester (BAPTA/AM) and fura-2 acetoxymethyl ester (fura-2/AM) were from Molecular Probes, Eugene, OR. Hyperfilm and [g 32 P]ATP were from Amersham, Arlington Heights, IL, and nitrocellulose membrane was from Schleicher & Schuell, Keene, NH.
Methods
Tissue preparation
Dispersed rat pancreatic acini were prepared as described previously [9 -11] . Unless otherwise stated, the standard incubation solution contained (in mM): HEPES (25.5) [pH 7.4]; NaCl (98); KCl (6); NaH 2 PO 4 (2.5); sodium pyruvate (5); sodium fumarate (5); sodium glutamate (5); glucose (11.5); CaCl 2 (0.5); MgCl 2 (1); glutamine (2); albumin 1% (w/v); trypsin inhibitor 1% (w/v); vitamin mixture, 1% (v/v) and amino acid mixture, 1% (w/v). The incubation solution was equilibrated with 100% O 2 and all incubations were performed with 100% O 2 as the gas phase.
Intracellular calcium measurement
After isolation, pancreatic acini were resuspended in NaHEPES medium containing 130 mM NaCl, 5 mM KCl, 20 mM HEPES, 1.2 mM KH 2 PO 4 , 10 mM D-glucose, 1 mM CaCl 2 , 0.1 mg/ml trypsin inhibitor, and loaded with 2 AM fura 2/AM for 30-40 min at 25 jC. Changes in [Ca 2 + ] i were assessed using a spectrofluorophotometer RF-5001PC (Shimadzu Europe GmbH, Duisburg, Denmark) as described previously [10] . Fluorescence was measured at 500 nm after excitation at 340 nm ( F 340 ) and 380 nm ( F 380 ). Values for [Ca 2 + ] i were calculated, after subtraction of background autofluorescence, as described previously [10] .
Immunoprecipitation
Immunoprecipitation of tyrosine-phosphorylated proteins was performed as described previously [9 -11] . Dispersed acini from one rat were preincubated with standard incubation solution without or with different inhibitors, at concentrations and times indicated, for up to 3 h at 37 jC. Aliquots (1 ml) were then incubated at 37 jC with different agonists at the concentrations and times indicated. Acinar lysates were obtained as described previously [9] using sonication in lysis buffer [50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% (w/v) NaN 3 , 1 mM EGTA, 0.4 mM EDTA, 2.5 Ag/ml aprotinin, 2.5 Ag/ml leupeptin, 1 mM PMSF and 0.2 mM Na 3 VO 4 ]. For tyrosine phosphor- ylation determination, lysates (500 Ag/ml) were preincubated with 4 Ag of anti-phosphotyrosine mAb (PY20) or 4 Ag anti-PKC-y polyclonal Ab and 25 Al of protein A -agarose overnight at 4 jC. Then the immunoprecipitates were washed three times with phosphate-buffered saline and further analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting.
Western blotting
Western blotting was performed as described previously [9 -11] . Anti-phosphotyrosine or anti-PKC-y immunoprecipitates were fractionated by SDS-PAGE using 10% polyacrylamide gels. Proteins with molecular masses higher than 60 kDa were transferred to nitrocellulose membranes. Membranes were blocked overnight at 4 jC using blotto [5% nonfat dried milk in a solution containing 50 mM Tris/ HCl pH 8.0, 2 mM CaCl 2 , 80 mM NaCl, 0.05% (v/v) Tween 20] and incubated for 2 h at 25 jC with 1 Ag/ml of antiphosphotyrosine mAb, 0.25 Ag/ml of anti-PKC-y polyclonal Ab, 0.25 Ag/ml of anti-p125 FAK mAb or 0.025 Ag/ml antipaxillin mAb. After incubation with the primary antibody, membranes were washed twice for 4 min with blotto and incubated for 45 min at 25 jC with anti-mouse IgGhorseradish peroxidase conjugate when using anti-phosphotyrosine as a primary antibody or anti-rabbit IgG -horseradish peroxidase conjugate when using anti-PKC-y polyclonal Ab. The membranes were finally washed with washing solution [50 mM Tris/HCl pH 8.0, 2 mM CaCl 2 , 80 mM NaCl, 0.05% (v/v) Tween 20], incubated with enhanced chemiluminescence detection reagents for 5 min, and exposed to Hyperfilm ECL. The density of bands on the film was measured using a scanning densitometer (Molecular Dynamics, Sunnyvale, CA). When reprobing was necessary, membranes were stripped of bound antibodies by incubation in stripping buffer (62.5 mM Tris/HCl pH 6.7, 100 mM 2mercaptoethanol, 2% (w/v) SDS) at 50 jC for 30 min with occasional agitation. Membranes were then incubated twice for 10 min with washing solution and blocked overnight at 4 jC using blotto. Immunodetection was performed as described above.
PKC-a kinase activity measurement
Acinar lysates (500 Ag/ml) were inmunoprecipitated with 4 Ag of anti-PKC-a mAb, 4 Ag of rabbit anti-mouse IgG polyclonal Ab, and 30 Al of protein A -agarose overnight at 4 jC. Kinase assays were performed using the protein kinase C assay kit from Upstate Biotechnology (Lake Placid, NY). Immune complexes bound to the protein A -agarose were washed two times with 1 ml of modified lysis buffer (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM Na 3 VO 4 , 5 Ag/ml aprotinin, 5 Ag/ml leupeptin and 1 mM PMSF), and two times with assay dilution buffer (20 mM MOPS, pH 7.2, 25 mM h-glycerophosphate, 1 mM sodium orthovanadate, 1 mM dithiothreitol and 1 mM CaCl 2 ). Following the last wash, the pelleted beads were resuspended in 40 Al of assay dilution buffer containing 5 Ag of phosphatidylserine and 0.5 Ag of diacylglycerol. The kinase reaction was initiated with the addition of myelin basic protein (50 Ag) and a magnesium/ATP mixture (75 mM MgCl 2 and 0.5 mM ATP) containing 10 ACi of [g-32 P] ATP (3000 Ci/mmol). The reaction mixtures were briefly mixed and incubated at room temperature for 15 min with occasional mixing. To stop the kinase reaction, 10 Al of 4 Â SDS sample buffer was added and samples were boiled for 5 min. Sample proteins were resolved using 4-20% SDS-PAGE gels. Gels were dried and analyzed in a phosphoimager (InstantImager, Packard Instruments Co., Meriden, CT).
Results
Tyrosine phosphorylation of PKC-in rat pancreatic acini in response to CCK A receptor activation: kinetics and dose dependence, and ability of CCK to activate PKC-
After incubating pancreatic acini with 10 nM CCK-8, cell lysates were subjected to immunoprecipitation with an anti-PKC-y polyclonal Ab and the immunoprecipitated proteins were analyzed by Western blotting with anti-phosphotyrosine mAb. CCK-8 ( Fig. 1 , upper panel) caused a marked increase in the tyrosine phosphorylation of PKC-y (lane 3). An identical result was obtained when the acini lysates were first immunoprecipitated with anti-phosphotyrosine mAb and then analyzed with anti-PKC-y polyclonal Ab (Fig. 1 , bottom panel, lane 3). Following stripping of the membrane used in Fig. 1 , top panel, from anti-phosphotyrosine antibodies, Western blotting with anti-PKC-y polyclonal Ab showed that the amount of PKC-y from acinar lysates was not altered by treatment with CCK-8 10 nM ( Fig. 1 , middle panel). These results demonstrated that PKC-y is expressed in rat pancreatic acini and that CCK-8 stimulates its tyrosine phosphorylation.
Tyrosine-phosphorylated PKC-y in unstimulated samples was consistently below the level of detection (Fig. 2) . However, tyrosine phosphorylation of PKC-y was a rapid consequence of the addition of 10 nM CCK-8 to pancreatic acini ( Fig. 2, upper panel ). An increase of 60 F 19% of maximum stimulation was detected 30 s after addition of CCK-8, reached a maximum within 5 min and was maintained for 72 F 15% of maximum for at least 30 min. The effect of CCK-8 on PKC-y tyrosine phosphorylation was concentration-dependent ( Fig. 2, lower panel) . At a 0.3 nM concentration, CCK-8 caused a 17% increase in PKC-y tyrosine phosphorylation, a half-maximal effect occurred at 1 nM and a maximal effect at 100 nM (Fig. 2, lower panel) . Reprobing the same blots with an anti-PKC-y mAb confirmed that an equivalent amount of PKC-y was inmunoprecipitated at each point (data not shown). These results demonstrate that activation of CCK A receptor in rat pancreatic acini causes rapid tyrosine phosphorylation of PKC-y in a concentrationdependent manner.
Numerous studies demonstrated that the pancreatic CCK A receptor exists in at least two binding states [4, 5, 27, 28] and each state has a different set of secondary messengers and different biological effects [27, 28] . CCK-JMV-180 is repor- Fig. 4 . Calcium dependence of CCK-8 and phorbol ester stimulation of PKC-y tyrosine phosphorylation in rat pancreatic acini. Pancreatic acini were pretreated for 30 min at 37 jC in a calcium-free medium (with EGTA 5 mM) either in the absence or presence of BAPTA-AM (50 AM). Acini were then incubated for a further 2.5 min with CCK-8 (10 nM) (lanes 5 and 6) or for a further 5 min with TPA (1 AM) (lanes 3 and 4) or with no additions (lanes 1 and 2). PKC-y tyrosine phosphorylation was determined by immunoprecipitation and Western blotting as described in the ted to be an agonist of the CCK A high affinity receptor state and an antagonist of the low affinity CCK A receptor state in rat pancreatic acini [27, 28] . Because of this ability to distinguish between the two affinity states of the CCK A receptor, we used this peptide to establish which of these states stimulates PKC-y tyrosine phosphorylation. Incubation of pancreatic acini with 0.1 or 1 AM CCK-JMV-180 had no effect on PKC-y tyrosine phosphorylation ( Fig. 3 , left panel). However, incubation of pancreatic acini with 1 AM CCK-JMV-180 caused an inhibition of CCK-8 stimulation (10 nM) of PKC-y tyrosine phosphorylation by 76 F 8% ( Fig. 3, left panel) . This result supports the conclusion that CCK-8 stimulation of PKC-y tyrosine phosphorylation is mediated by the low CCK A receptor affinity state. The fact that the tyrosine phosphorylation of PKC-y occurs in the CCK-8-concentration range for the occupation of low affinity state [4] also supports this idea ( Fig. 3 , lower panel). 
Effect of intracellular calcium concentration in CCK-8 stimulated PKC-tyrosine phosphorylation
CCK A receptor activation results in the release of Ca 2 + from intracellular stores followed by the influx of Ca 2 + from the medium [5, 10, 28, 29] . To examine the role of intracellular calcium in CCK-8-stimulated PKC-y tyrosine phosphorylation, we used two different approaches. First, we determined whether an increase on [Ca 2 + ] i could alter tyrosine kinase pathways. To assess this we used A23187, a calcium ionophore, and thapsigargin, an agent that specifically inhibits the endoplasmic reticulum Ca 2 + -ATPase [29] , depleting Ca 2 + from intracellular compartments and causing an increase in the [Ca 2 + ] i . Calcium ionophore (1 AM) and thapsigargin (1 AM) under conditions known to increase [Ca 2 + ] i [29] , did not modify PKC-y tyrosine phosphorylation (Fig. 3 , right panel). In the second approach, we pretreated pancreatic acini (1 h in a calcium-free medium containing 5 mM EGTA) with BAPTA (50 AM) or with thapsigargin (10 AM) to completely inhibit the subsequent CCK-8 induced [Ca 2 + ] i increase. Results with BAPTA are shown in Fig. 4 . Neither BAPTA (Fig. 4, lanes 1, 2) nor thapsigargin significantly modified the basal tyrosine phosphorylation in control cells and neither pretreatment with BAPTA nor thapsigargin inhibited CCK-8 or TPA-stimulated PKC-y tyrosine phosphorylation. However, treatment of acini with BAPTA ( Fig.  4, lanes 3 -6) in a calcium-free medium significantly increased CCK-8-and TPA-induced PKC-y tyrosine phosphorylation by more than 50% over that seen with CCK-8 or TPA alone. These results demonstrate that increases in [Ca 2 + ] i alone do not lead to an increase in PKC-y tyrosine phosphorylation and that intracellular calcium mobilization Fig. 7 . Effect of the PKC inhibitor GF 109203X on CCK-8 and phorbol ester stimulation of p125 FAK , paxillin and PKC-y tyrosine phosphorylation in rat pancreatic acini. Pancreatic acini were pretreated with 5 AM GF 109203X for 2 h at 37 jC and then incubated for a further 2.5 min with 10 nM CCK-8 or for 5 min with 1 AM TPA or with no additions (control). PKC-y tyrosine phosphorylation was detected as described in Fig. 2 legend. p125 FAK and paxillin tyrosine phosphorylation was determined as described previously [9] . is not essential for the ability of CCK-8 to stimulate PKC-y tyrosine phosphorylation. However, because the magnitude of CCK-stimulated PKC-y tyrosine phosphorylation was augmented by inhibiting the CCK-stimulated increase in [Ca 2 + ] i , these results suggest that the CCK-stimulated increases in [Ca 2 + ] i could be activating an inhibitory process that was counter-regulating the increase caused by CCK in PKC-y tyrosine phosphorylation.
Role of phosphoinositides in CCK-8-stimulated PKCtyrosine phosphorylation
As reported previously [5, 30] , the metabolism of phosphoinositides by the different phosphoinositide kinases is a key event in transmitting signals in response to a variety of hormones and growth factors including CCK. Because recent studies suggest PI-3 kinase activity may be important in PKC-y tyrosine phosphorylation caused by antigen receptor cross-linking in B cells [31] , we investigated the effect of two known PI-3 kinase inhibitors, LY 294002 and wortmannin, on CCK-stimulated PKC-y tyrosine phosphorylation.
Treatment of pancreatic acini with LY 294002 (100 AM) or wortmannin (1 AM) for 1 h had no effect on CCK-8 stimulation of PKC-y tyrosine phosphorylation (Fig. 5 , lanes 5 and 6). However, we have previously shown that under the same experimental conditions, both LY 294002 and wortmannin inhibited CCK-8, EGF, and carbachol stimulation of p125 FAK , p130 Cas , and paxillin tyrosine phosphorylation in pancreatic acini [32] . These results demonstrate that PI-3 kinase activation is not essential for the ability of CCK-8 to stimulate PKC-y tyrosine phosphorylation in rat pancreatic acini.
Effect of PKC activation on PKC-tyrosine phosphorylation
CCK A receptor occupation causes activation of PLC with the hydrolysis of phosphatidylinositol 4,5-bisphosphate, which increases production of inositol phosphates and diacylglycerol, which in turn leads to mobilization of cellular calcium and activation of PKC isoforms, respectively [5, 28] . Previous studies have demonstrated that rat Fig. 8 . Dose -inhibition curve of GF 109203X on CCK-8 and phorbol ester stimulation of PKC-y tyrosine phosphorylation in rat pancreatic acini. Pancreatic acini were preincubated with the indicated concentrations of GF 109203X for 2 h at 37 jC and then incubated for a further 2.5 min with 10 nM CCK-8, for 5 min with 1 AM TPA, or with no additions. PKC-y tyrosine phosphorylation was determined by immunoprecipitation and Western blotting as described in pancreatic acini posses both cPKCs and nPKCs [25, 26] . To determine whether activation of cPKC or nPKC isoforms modify the tyrosine phosphorylation of PKC-y, pancreatic acini were treated with the phorbol ester, TPA, which directly activates both cPKC and nPKC [15, 33] . Treatment of pancreatic acini with TPA caused a marked increase in the tyrosine phosphorylation of PKC-y (Fig. 1, top panel, lane 2) determined by using immunoprecipitation with an anti-PKC-y and Western Blotting with anti-phosphotyrosine mAb. Identical results were obtained when both antibodies were used in reverse order (Fig 1, bottom panel, lane  2) . Western blotting of PKC-y immunoprecipitated with anti-PKC-y polyclonal Ab showed that the amount of PKC-y from cell lysates was not altered by treatment with TPA for 5 min (Fig. 1, middle panel, lanes 1 and 2) . Tyrosine phosphorylation of PKC-y was a rapid consequence of the addition of 1 AM TPA to pancreatic acini ( Fig. 6 , upper panel). The maximal effect was observed within 5 min, then decreased slowly after 10 min, and remained 46 F 3% of maximal response after 30 min. The effect of TPA on PKC-y tyrosine phosphorylation was concentrationdependent ( Fig. 6 , lower panel) with TPA causing a halfmaximal effect at 0.3 AM and a maximal effect at 10 AM (Fig. 6, lower panel) .
With a number of cellular processes in rat pancreatic acini [4, 10, 28] , simultaneous increases in [Ca 2 + ] i and PKC activation have a potentiating effect. To determine whether similar effects occurring with PKC-y tyrosine phosphorylation, the calcium ionophore, A23187, or thapsigargin in a calcium-containing medium were added with TPA ( Fig. 3,  right panel) . The simultaneous stimulation with both TPA (0.1 AM) and A23187 (1 AM) or thapsigargin (1 AM) did not modify the PKC-y tyrosine phosphorylation achieved with TPA alone (Fig. 3, right panel) .
To determine whether PKC activation might be involved in mediating the CCK-8-stimulated changes in PKC-y tyrosine phosphorylation, we examined the effect of the broad spectrum PKC inhibitor, GF 109203X [34, 35] . Pretreatment of pancreatic acini with GF 109203X (5 AM) alone for 2 h had no effect on basal PKC-y tyrosine phosphorylation (Fig. 7,  right panel, lanes 1 and 2) . However, under these conditions GF 109203X (5 AM) significantly ( P < 0.01) increased CCK-8 (10 nM) and TPA (1 AM) stimulation of PKC-y tyrosine phosphorylation to 210 F 34% and 203 F 32% of control, respectively (Fig. 7, right panel) over the levels seen with CCK-8 without pretreatment with GF 109203X. In the same lysates, GF 109203X pretreatment inhibited completely TPA-stimulated p125 FAK and paxillin tyrosine phosphorylation ( Fig. 7, left panel) , as we have previously shown [9] . Previous studies have shown that GF 109203X has a greater ability to inhibit cPKCs than nPKCs, but can inhibit both at high concentrations [35, 36] . To investigate further this possibility, we pretreated the pancreatic acinar cells for 2 h with different concentrations of GF 109203X (1-100 AM) (Fig.  8 ). Low GF 109203X concentrations (1 and 5 AM) significantly increased the tyrosine phosphorylation of PKC-y Fig. 9 . Effect of the cPKC inhibitor Gö 6976 on CCK-8 and phorbol ester stimulation of PKC-y tyrosine phosphorylation in rat pancreatic acini. Pancreatic acini were pretreated for 2 h at 37 jC either in the absence or presence of 10 AM Gö 6976 and then incubated for a further 2.5 min with CCK-8 (10 nM) or 5 min with TPA (1 AM). PKC-y tyrosine phosphorylation was detected as described in Fig. 2 stimulated by TPA or CCK-8 (Fig. 8, lanes 2-4 and 7-9 ). Pretreatment with high concentrations of GF 109203X (30 and 100 AM) reduced the tyrosine phosphorylation of PKC-y stimulated by CCK-8 or TPA by >50% (Fig. 8) . These results suggest that at lower concentrations, GF 109203X reduces the effect of activation of an inhibitory factor, perhaps a conventional PKC, and at higher concentrations, inhibits all PKCs as seen in other cell systems [35, 36] .
To study further the role of activation of possible PKCs in mediating CCK-8-stimulated increases in PKC-y tyrosine phosphorylation, we used Gö 6976 and safingol, which in other cell systems are more selective cPKC inhibitors [35 -39] . Pretreatment of pancreatic acini with Gö 6976 (10 AM) alone for 2 h had no effect on basal PKC-y tyrosine phosphorylation (Fig. 9, lane 2) . However, Gö 6976 increased significantly ( P < 0.01) by 182 F 49% and 204 F 46% the PKC-y tyrosine phosphorylation stimulated by CCK-8 (10 nM) and TPA (1 AM), respectively ( Fig. 9 ). Treatment with safingol (10 AM) for 2 h increased significantly ( P < 0.01) by 75 F 23% and 180 F 77% the PKC-y tyrosine phosphorylation stimulated by CCK-8 (10 nM) and TPA (1 AM), respectively ( Fig. 10, lower panel) . Under the same conditions, safingol alone had no effect on basal PKC-y tyrosine phosphorylation (Fig. 10, lower panel, lane  2) or basal PKC-a kinase activity (Fig. 10, lane 3) but markedly inhibited the TPA-stimulated PKC-a kinase activity ( Fig. 10, upper panel, lanes 2 and 4) . The results with TPA and PKC inhibitors demonstrate that activation of different PKC isoforms in pancreatic acini have both stimulatory and inhibitory effects on the tyrosine phosphorylation of PKC-y.
Discussion
Numerous stimulants cause tyrosine phosphorylation of the nPKC isoform, PKC-y, including growth factors [14, 16, 19, 23, 40] , oxidative stress [41] , Ras [19] , and activation of a few G protein-coupled receptors (angiotensin II, substance P, muscarinic cholinergic, ATP, a-adrenergic) [16, 42, 43] . A number of results support the conclusion that stimulation of the CCK A -R in rat pancreatic acini results in PKC-y tyrosine phosphorylation, which is mediated through activation of its low affinity state. First, whether immunoprecipitation was performed with an anti-PKC-y antibody and Western blotting performed with an anti-phosphotyrosine mAb or the same antibodies used in reverse order, CCK stimulated phosphorylation of a single immunoreactive band. Second, the dose -response curve for PKC-y tyrosine phosphorylation occurred over the concentration range that CCK-8 stimulates activation of its low affinity receptor state [4, 27] . Numerous binding studies demonstrate the pancreatic CCK A -R exists in high-and low-affinity states [4, 27, 44] . and activation of the two states are associated with stimulation of different secondary messengers and biologic responses [44, 45] . The CCK-8 analogue, CCK-JMV-180, is an agonist Fig. 10 . Effect of the cPKC inhibitor safingol on TPA-stimulated PKC-a kinase activity and on CCK-8 and TPA stimulation of PKC-y tyrosine phosphorylation in rat pancreatic acini. Top panel: Acinar lysates were incubated with TPA (1 AM) for 5 min in the absence or presence of 10 AM of safingol. PKC-a kinase activity was measured as described in Methods. The figure shows results from a typical experiment representative of three others. Bottom panel: Pancreatic acini were pretreated for 2 h at 37 jC either in the absence or presence of 10 AM safingol and then incubated for a further 2.5 min with CCK-8 (10 nM) or 5 min with TPA (1 AM). PKC-y tyrosine phosphorylation was detected as described in Fig. 2 at the CCK A high affinity and an antagonist at the low affinity receptor state in rat pancreatic acini [27] . CCK-JMV-180 did not stimulate tyrosine phosphorylation of PKC-y, suggesting that CCK-8's ability to stimulate PKC-y tyrosine phosphorylation is due to activation of the low affinity CCK A -R state. This conclusion was confirmed by demonstrating that CCK-JMV-180 inhibited CCK-8's ability to stimulate PKC-y tyrosine phosphorylation due to its ability to act as a receptor antagonist of this state [27] .
CCK's stimulation of PKC-y tyrosine phosphorylation has similarities and differences from both the ability of other stimulants in other cells to cause PKC-y tyrosine phosphorylation and the ability of CCK A -R activation to cause tyrosine phosphorylation of other proteins in rat pancreatic acini. The time course of CCK stimulation of PKC-y tyrosine phosphorylation reached a maximum, then decreased, suggesting that a tyrosine phosphatase was likely also activated. This time course is similar to that seen with insulin stimulation of PKC-y tyrosine phosphorylation in rat skeletal muscle [23] , but differs from that caused by carbachol or substance P in salivary epithelial cells in which the initial increase in tyrosine phosphorylation completely disappeared within 15 min [16] , or thrombin in platelets in which a biphasic temporal pattern of PKC-y phosphorylation was seen [46] . At present, the significance of the variable temporal patterns of PKC-y tyrosine phosphorylation in different cells with different stimuli is unknown. CCK A -R activation in rat pancreatic acini has been shown to cause tyrosine phosphorylation of p125 FAK [9] , paxillin [9] , p130 Cas [11] , PYK2/CAKh [10] , Jun kinase [5, 47] , MAP kinase [5, 48] , and PI-3 kinase [49] . In contrast to PKC-y tyrosine phosphorylation, which is mediated only by activation of the low affinity state of the CCK A -R, stimulation of tyrosine phosphorylation of p125 FAK , paxillin, and PYK2/ CAKh [10] in rat pancreatic acini by CCK was stimulated by activation of both the high and low CCK A -R states. These results demonstrate that not only are the phospholipase A 2 and PLC cascades coupled differently to high and low affinity CCK A -R states as described previously [44] , but also the tyrosine phosphorylation cascades activated by CCK A -R are differentially coupled to these two different receptor states.
Activation of the CCK A -R causes stimulation of PLC activity [4, 5] . Even though PKC-y is a calcium-independent, DAG-dependent kinase [14, 15] and the role of DAG in stimulating its kinase activity has been well studied [14, 15, 33] , much less is known about the participation of the PLC cascade in mediating PKC-y tyrosine phosphorylation from studies in different cells by various stimuli. Inhibition of PLC activation simulated by substance P or carbachol in salivary epithelial cells [18] , or in B cells due to activation of the B cell antigen receptor [50] , resulted in inhibition of PKC-y tyrosine phosphorylation caused by these stimuli, demonstrating that activation of the PLC cascades is needed to stimulate PKC-y tyrosine phosphorylation in these cells. However, increasing [Ca 2 + ] i in salivary epithelial cells by a calcium ionophore [16, 18] did not stimulate tyrosine phosphorylation of PKC-y, or inhibition of [Ca 2 + ] i increases caused by substance P or carbachol in salivary epithelial cells [18] did not inhibit their ability to cause PKC-y tyrosine phosphorylation, suggesting that changes in [Ca 2 + ] i alone were not sufficient to stimulate or inhibit stimulated PKC-y tyrosine phosphorylation in these cells. In contrast to the lack of effect changes in [Ca 2 + ] i , the phorbol ester, TPA, which can activate all cPKC and nPKC isoforms [15, 33] , stimulated PKC-y tyrosine phosphorylation in salivary epithelial cells [16] and in 32D hematopoietic cell line [51] . Whereas these results would suggest that in these tissues PKC activation due to DAG generation is particularly important in regulating the tyrosine kinase(s) responsible for PKC-y tyrosine phosphorylation, results in other cells suggest that cell-specific differences exist. For example, in B cells [50] where activation of the B cell antigen receptor causes PKC-y tyrosine phosphorylation in a PLC-dependent manner, TPA does not cause tyrosine phosphorylation, suggesting that activation of DAG-stimulated pathways alone is not sufficient to stimulate PKC-y tyrosine phosphorylation in this cell. In our study a number of results support the conclusion that both CCK-stimulated increases in DAG and changes in pancreatic acinar [Ca 2 + ] i are likely important in determining the maximal extent of PKC-y phosphorylation stimulated by CCK A -R activation; however, activation of these two cascades have different effects (Fig. 11) . First, neither increasing [Ca 2 + ] i using the calcium ionophore, A23187, nor using the Ca 2 + -ATPase inhibitor, thapsigargin [29] , resulted in an increase in PKC-y tyrosine phosphorylation. Second, inhibition of the increases in [Ca 2 + ] i caused by CCK A -R activation using either BAPTA or thapsigargin did not inhibit CCK-stimulated increases in PKC-y tyrosine phosphorylation. The lack of effect of changes in [Ca 2 + ] i either alone or in combination with TPA supports the conclusion that increases in [Ca 2 + ] i caused by a CCK A -R-stimulated increase in PLC activity in pancreatic acini are not essential for CCK A -R activation to stimulate PKC-y tyrosine phosphorylation. These results are similar to that reported with stimulation of PKC-y tyrosine phosphorylation in salivary epithelial cells by substance P or carbachol [16, 18] and B cell receptor activation in B cells [50] . Third, the phorbol ester, TPA, which can mimic the effects of endogenous increases in DAG in both activating PKCs and causing PKC translocation to the plasma membrane [14, 15, 28, 33] , stimulated PKC-y tyrosine phosphorylation to the same extent seen with CCK A -R activation. These results suggest that increases in DAG due to CCK A -R activation in pancreatic acini are likely the principal mechanism leading to CCK stimulation of PKC-y tyrosine phosphorylation.
In previous studies, CCK A -R activation stimulates both PLC and phospholipase D (PLD), leading to generation of DAG [25, 28, 45] . A number of results support the conclusion that the generation of DAG from PLC activation by CCK is the important cascade mediating the increase in PKC-y tyrosine phosphorylation seen with CCK A -R activation. First, CCK A -R-mediated PLD stimulation is mediated by activation of the high affinity CCK A -R state [27, 45] , whereas we show that CCK-mediated PKC-y tyrosine phosphorylation is due to activation of the low affinity state only, whose activation has been shown to be coupled to PLC stimulation [27, 52] . Second, CCK-JMV, which only activates the high affinity state [4] and has been shown to activate PLD [25, 27, 45] , but not PLC [25, 27, 45, 52] , did not stimulate an increase in PKC-y tyrosine phosphorylation. Third, a previous study [25] has shown that CCK-mediated PKC-y translocation in pancreatic acini is mediated only by DAG generated by PLC activation, not from PLD activation.
In some cells, stimulation of PKC-y tyrosine phosphorylation requires activation of PI-3 kinase [31] . CCK A -R activation in pancreatic acini has been shown to activate PI-3 kinase [45] and it is proposed this activation is involved in mediating CCK's stimulation of tyrosine phosphorylation of p125 FAK , p130 Cas , and paxillin [11, 32] . In the present study we provide evidence that PI-3 kinase activation is not required for stimulation of PKC-y tyrosine phosphorylation, using two different inhibitors of PI-3 kinase: wortmannin, which inhibits PI-3 kinase catalytic activity, and LY 294002, which inhibits by acting at the ATP binding site of the PI-3 kinase [30] . These results are similar to the lack of involvement of PI-3 kinase in TPA-or carbachol-stimulation of PKC-y tyrosine phosphorylation in salivary epithelial cells [16] ; however, they differ from results of B cell antigen receptor stimulation of PKC-y tyrosine phosphorylation, which is dependent on PI-3 kinase activation [31] .
The role of activation of PKCs in stimulation of the tyrosine kinase(s) that cause PKC-y tyrosine phosphorylation is unknown. In the present study, to provide insight into this area we investigated the effect of incubations in calcium-free conditions inhibiting activation of cPKCs and of several PKC inhibitors with different PKC isoform selectivities. CCK or TPA in calcium-free conditions caused an increase in PKC-y tyrosine phosphorylation, suggesting activation of cPKCs could be having an inhibitory effect. To provide additional support for this conclusion, the effects of GF 109203X, a broad-range PKC inhibitor with greater ability to inhibit cPKCs but which also can inhibit nPKCs [34 -36] , and Gö 6976 and safingol, which are more specific inhibitors for cPKCs [35 -39] , were determined. Previous studies show that rat pancreatic acinar cells possess only one cPKC (PKC-a), two nPKCs (PKC-y and PKC-q), and the atypical PKC, PKC-~ [25, 26] . A number of our results support the conclusion that activation of at least the PKC isoform, PKC-a, and maybe others, is involved in regulating CCK A -R stimulation of tyrosine kinases or tyrosine phosphatases that alter the tyrosine phosphorylation of PKC-y. First, GF 109203X had a biphasic effect on CCKstimulated PKC-y tyrosine phosphorylation. The augmentation of the ability of CCK to stimulate PKC-y tyrosine phosphorylation when GF 109203X was added at low concentrations is consistent with the suggestion that inhibition of a cPKC is having an inhibitory effect. The inhibitory effect of GF 109203X at higher concentrations is compatible with its ability to inhibit all nPKC and cPKCs, including PKC-y, at these concentrations. Second, studies using the structurally unrelated cPKC-selective antagonists, Gö 6976 and safingol [35 -37,39] , suggest that inhibition of a cPKC was in fact responsible for the increase in CCKstimulated PKC-y tyrosine phosphorylation seen with GF 109203X.
On the basis of the results in this study, the model shown in Fig. 11 can be proposed for the ability of CCK A -R activation in pancreatic acinar cells to cause PKC-y tyrosine phosphorylation. CCK A -R activation of PLC resulting in increases in [Ca 2 + ] i from intracellular sources [5] is not essential for CCK to cause stimulation of PKC-y tyrosine phosphorylation. However, CCK A -R-activation-stimulated increases in [Ca 2 + ] i , in combination with increases in DAG, activate PKC-a, which has an inhibitory effect on CCK-stimulated PKC-y tyrosine phosphorylation. The inhibitory effect of PKC-a could be due to either inhibition of tyrosine kinase(s) or activation of tyrosine phosphatase(s). We have no direct evidence to favor either of these two possibilities. However, CCK A -R activation in rat pancreatic acini has been shown to increase protein tyrosine phosphatase activity [45] . Furthermore, with CCK-stimulated PKC-y tyrosine phosphorylation in the present study as well as in others [9] [10] [11] , there was a fall-off in the magnitude of maximal stimulation with time, suggesting that tyrosine phosphatases are also stimulated by CCK A -R activation [9 -11] . CCK A -R activation in pancreatic acini causes an increase in DAG from activation of phospholipases [25] and our results are consistent with the conclusion that this increase alone from PLC activation without changes in [Ca 2 + ] i can activate the tyrosine kinase cascade causing PKC-y tyrosine phosphorylation. The evidence for this is that TPA, which can mimic the actions of endogenous DAG, alone stimulates PKC tyrosine phosphorylation in pancreatic acini. Also supporting this conclusion is the result that CCK-JMV, which activates phospholipase D and not PLC [25, 27, 45, 52] , failed to stimulate PKC-y tyrosine phosphorylation. The mechanism by which TPA or CCK activates the tyrosine kinase that phosphorylates PKC-y, as indicated in Fig. 11 , is by activation of an nPKC, which then activates the tyrosine kinases. We have no direct evidence to support this in the present study. However, the ability of high concentrations of GF 109203X to inhibit either TPA-or CCK-stimulated tyrosine phosphorylation raises this possibility, because at these concentrations it inhibits all of the cPKCs and nPKCs which are found in pancreatic acini [25, 26] . This possibility is indicated on the diagram in Fig. 11 by a query because of lack of direct evidence to support it and also because some evidence supports a second possibility. Recently it was proposed in B cells that TPA or DAG causes PKC-y to translocate to the plasma membrane, where a tyrosine kinase, perhaps a member of the Src family, can phosphorylate it [50] . In a number of different cells, Src family members promote PKC-y tyrosine phosphorylation [14, 17, 18, 21] and previous studies demonstrate that both TPA treatment and CCK A -R activation in rat pancreatic acinar cells cause translocation of PKC-y to the plasma membrane [25] as well as activation of Src [53] . The possibility of this pathway occurring in rat pancreatic acini is further supported by the demonstration that the CCK A -R activation in these cells activates Src through its low affinity receptor state, which is the same receptor state we demonstrate in this study as responsible for mediating CCK-stimulated increases in PKC-y tyrosine phosphorylation. A recent study [21] demonstrates that Src-promoted PKC-y tyrosine phosphorylation leads to increased PKC-y degradation and this decreases the amount of PKC-y in the cell. Further experiments are required to establish if CCK mediates a similar effect in rat pancreatic acini. However, if CCK activates this mechanism in acini, the simultaneous activation of PKC-a by CCK, which inhibits the amount of PKC-y tyrosine phosphorylation, presumably could inhibit the degradation of PKC-y after a prolonged time period resulting in stabilization of its amount in the cell. This pathway could be the second counter-regulatory mechanism involving PKC-a that regulates the amount of PKC-y abundance. Recently [54] , increased expression of PKC-a mRNA has been shown to increase the abundance of PKC-y mRNA and PKC-y protein, demonstrating that PKC-a is uniquely involved in cross-regulating PKC-y abundance.
